Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays
- PMID: 16963746
- DOI: 10.1099/vir.0.81906-0
Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays
Abstract
Studies of Epstein-Barr virus (EBV)-positive cell lines have identified several forms of virus latency, but the patterns of virus gene expression in EBV-positive tumour cells appear more variable. However, it is unclear to what extent these differences merely reflect the increased sensitivities of different detection methods. Here, the design and validation of novel real-time RT-PCR assays to quantify relative levels of EBV transcripts are described. When the new assays were used to screen a collection of endemic Burkitt's lymphoma tumours, abundant Qp-driven EBNA1 expression was found, whereas the other latent transcripts (with the exception of LMP2A) were either absent or detectable only at trace levels. Analysis of 12 nasopharyngeal carcinoma biopsies revealed significant levels of EBNA1 and LMP2A transcripts in almost every case but, in contrast to previous reports, LMP1 expression was undetectable. These new quantitative assays may help to provide a clearer picture of EBV gene expression in tumour material.
Similar articles
-
Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.Br J Cancer. 1996 Aug;74(4):625-31. doi: 10.1038/bjc.1996.412. Br J Cancer. 1996. PMID: 8761381 Free PMC article.
-
Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.J Virol. 1992 May;66(5):2689-97. doi: 10.1128/JVI.66.5.2689-2697.1992. J Virol. 1992. PMID: 1313894 Free PMC article.
-
Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.J Clin Virol. 2005 Sep;34(1):26-34. doi: 10.1016/j.jcv.2004.12.016. J Clin Virol. 2005. PMID: 16087121
-
Epstein-Barr virus: 40 years on.Nat Rev Cancer. 2004 Oct;4(10):757-68. doi: 10.1038/nrc1452. Nat Rev Cancer. 2004. PMID: 15510157 Review.
-
Epstein-Barr virus and oncogenesis: from latent genes to tumours.Oncogene. 2003 Aug 11;22(33):5108-21. doi: 10.1038/sj.onc.1206556. Oncogene. 2003. PMID: 12910248 Review.
Cited by
-
Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A.Antiviral Res. 2012 Jul;95(1):49-56. doi: 10.1016/j.antiviral.2012.05.003. Epub 2012 May 16. Antiviral Res. 2012. PMID: 22609829 Free PMC article.
-
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.PLoS Pathog. 2015 Jun 11;11(6):e1004906. doi: 10.1371/journal.ppat.1004906. eCollection 2015 Jun. PLoS Pathog. 2015. PMID: 26067064 Free PMC article.
-
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival.Blood. 2007 Nov 15;110(10):3715-21. doi: 10.1182/blood-2007-05-090142. Epub 2007 Aug 6. Blood. 2007. PMID: 17682125 Free PMC article.
-
Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas.Pathogens. 2012 Oct 8;1(2):83-101. doi: 10.3390/pathogens1020083. Pathogens. 2012. PMID: 25436766 Free PMC article.
-
Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis.Oncogene. 2009 Mar 19;28(11):1471-6. doi: 10.1038/onc.2008.492. Epub 2009 Feb 2. Oncogene. 2009. PMID: 19182823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources